ANIXA BIOSCIENCES, INC. Interest Income, Other
ANIXA BIOSCIENCES, INC. (ANIX) reported Interest Income, Other of $112.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. interest income, other for the quarter ending 2026-07-31 was $112.00K, a 28.21% decline year-over-year.
- ANIXA BIOSCIENCES, INC. interest income, other for the quarter ending 2026-04-30 was $111.00K, a 41.58% decline year-over-year.
- ANIXA BIOSCIENCES, INC. interest income, other for the quarter ending 2026-01-31 was $131.00K, a 24.28% decline year-over-year.
- ANIXA BIOSCIENCES, INC. interest income, other for the quarter ending 2025-10-31 was $154.00K, a 38.40% decline year-over-year.
- ANIXA BIOSCIENCES, INC. interest income, other for fiscal 2025 was $673.00K, a 40.60% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. interest income, other for fiscal 2024 was $1.13M, a 4.81% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. interest income, other for fiscal 2023 was $1.08M, a 939.42% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. interest income, other for fiscal 2022 was $104.00K, a 5100.00% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 3 month as first filed | Interest Income, Other 6 month | Interest Income, Other 6 month as first filed | Interest Income, Other 9 month | Interest Income, Other 9 month as first filed | Interest Income, Other 12 month | Interest Income, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $112.00K 10-Q · filed 2026-09-09 | $223.00K derived: sum of 2 quarters · filed 2026-09-09 | $354.00K 10-Q · filed 2026-09-09 | $508.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | $111.00K 10-Q · filed 2026-06-10 | $242.00K 10-Q · filed 2026-06-10 | $396.00K derived: sum of 3 quarters · filed 2026-06-10 | $552.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | $131.00K 10-Q · filed 2026-03-09 | $285.00K derived: sum of 2 quarters · filed 2026-03-09 | $441.00K derived: sum of 3 quarters · filed 2026-09-09 | $631.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $310.00K derived: sum of 2 quarters · filed 2026-09-09 | $500.00K derived: sum of 3 quarters · filed 2026-09-09 | $673.00K 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | $156.00K 10-Q · filed 2026-09-09 | $346.00K derived: sum of 2 quarters · filed 2026-09-09 | $519.00K 10-Q · filed 2026-09-09 | $769.00K derived: sum of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | $190.00K 10-Q · filed 2026-06-10 | $363.00K 10-Q · filed 2026-06-10 | $613.00K derived: sum of 3 quarters · filed 2026-06-10 | $890.00K derived: sum of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | $173.00K 10-Q · filed 2026-03-09 | $423.00K derived: sum of 2 quarters · filed 2026-03-09 | $700.00K derived: sum of 3 quarters · filed 2026-03-09 | $987.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $527.00K derived: sum of 2 quarters · filed 2026-01-12 | $814.00K derived: sum of 3 quarters · filed 2026-01-12 | $1.13M 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | $277.00K 10-Q · filed 2025-09-10 | $564.00K derived: sum of 2 quarters · filed 2025-09-10 | $883.00K 10-Q · filed 2025-09-10 | $1.21M derived: sum of 4 quarters · filed 2025-09-10 | ||||
| 2024-04-30 | $287.00K 10-Q · filed 2025-05-28 | $606.00K 10-Q · filed 2025-05-28 | $936.00K derived: sum of 3 quarters · filed 2025-05-28 | $1.23M derived: sum of 4 quarters · filed 2025-05-28 | ||||
| 2024-01-31 | $319.00K 10-Q · filed 2025-03-11 | $649.00K derived: sum of 2 quarters · filed 2025-03-11 | $945.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.20M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-10-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $626.00K derived: sum of 2 quarters · filed 2025-01-10 | $879.00K derived: sum of 3 quarters · filed 2025-01-10 | $1.08M 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | $296.00K 10-Q · filed 2024-09-06 | $549.00K derived: sum of 2 quarters · filed 2024-09-06 | $751.00K 10-Q · filed 2024-09-06 | $831.00K derived: sum of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | $253.00K 10-Q · filed 2024-06-04 | $455.00K 10-Q · filed 2024-06-04 | $535.00K derived: sum of 3 quarters · filed 2024-06-04 | $557.00K derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | $202.00K 10-Q · filed 2024-03-12 | $282.00K derived: sum of 2 quarters · filed 2024-03-12 | $304.00K derived: sum of 3 quarters · filed 2024-03-12 | $305.00K derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $102.00K derived: sum of 2 quarters · filed 2024-01-16 | $103.00K derived: sum of 3 quarters · filed 2024-01-16 | $104.00K 10-K · filed 2024-01-16 | ||||
| 2022-07-31 | $22.00K 10-Q · filed 2023-09-06 | $23.00K derived: sum of 2 quarters · filed 2023-09-06 | $24.00K 10-Q · filed 2023-09-06 | $24.00K derived: sum of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | $1.00K 10-Q · filed 2023-06-14 | $2.00K 10-Q · filed 2023-06-14 | $2.00K derived: sum of 3 quarters · filed 2023-06-14 | $2.63K derived: sum of 4 quarters · filed 2023-06-14 | ||||
| 2022-01-31 | $1.00K 10-Q · filed 2023-03-17 | $1.00K derived: sum of 2 quarters · filed 2023-03-17 | $1.63K derived: sum of 3 quarters · filed 2023-03-17 | $2.02K derived: sum of 4 quarters · filed 2023-03-17 | ||||
| 2021-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $626.00 derived: sum of 2 quarters · filed 2023-01-04 | $1.02K derived: sum of 3 quarters · filed 2023-01-04 | $2.00K 10-K · filed 2023-01-04 | $2.32K 10-K · filed 2022-01-04 | |||
| 2021-07-31 | $626.00 10-Q · filed 2021-09-01 | $1.02K derived: sum of 2 quarters · filed 2021-09-01 | $2.00K 10-Q · filed 2022-09-09 | $1.77K 10-Q · filed 2021-09-01 | $3.23K derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2021-04-30 | $393.00 10-Q · filed 2021-06-10 | $1.00K 10-Q · filed 2022-06-10 | $1.15K 10-Q · filed 2021-06-10 | $2.61K derived: sum of 3 quarters · filed 2022-03-11 | $9.88K derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2021-01-31 | $1.00K 10-Q · filed 2022-03-11 | $754.00 10-Q · filed 2021-03-11 | $2.22K derived: sum of 2 quarters · filed 2022-03-11 | $9.48K derived: sum of 3 quarters · filed 2022-03-11 | $21.63K derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | $1.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $8.48K derived: sum of 2 quarters · filed 2022-01-04 | $20.63K derived: sum of 3 quarters · filed 2022-01-04 | $33.92K 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | $7.27K 10-Q · filed 2021-09-01 | $19.41K derived: sum of 2 quarters · filed 2021-09-01 | $32.71K 10-Q · filed 2021-09-01 | |||||
| 2020-04-30 | $12.15K 10-Q · filed 2021-06-10 | $25.44K 10-Q · filed 2021-06-10 | ||||||
| 2020-01-31 | $13.29K 10-Q · filed 2021-03-11 | |||||||
| 2019-10-31 | $71.35K 10-K · filed 2021-01-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |